Statistics Act, 1999
R 385
Medicines and Related Substances Control Act, 1965 (Act No. 101 of 1965)NoticesFees Payable in terms of the Provisions of the Medicines and Related Substances Act, 19657. Inspections to assess the quality, safety and efficacy of medicines or scheduled substances |
| (a) | Local manufacturing site: R715/h: |
| (b) | International manufacturing sites (excluding Southern Africa Development Community countries): R4 400/h |
| (c) | International manufacturing sites in Southern Africa Development Community countries: R2 000/h: |
| (d) | Wholesale sites: R6 050; |
| (e) | Distributor sites, Local: R6 050; |
| (f) | Clinical trial site; Local: R715/h; |
| (g) | International clinical trial site (excluding Southern Africa Development Community countries): R4 400/h: |
| (h) | International clinical trial sites in Southern Africa Development Community countries: R2 000/h: |
| (i) | Local pharmacovigilance inspection: R715/h |
| (j) | International pharmacovigilance inspection (excluding Southern Africa Development Community countries): R4 400/h |
| (k) | International pharmacovigilance inspection in Southern Africa Development Community countries: R2 000/h |
